Beta blocker therapy is associated with reduced depressive symptoms 12 months post percutaneous coronary intervention

Journal of Affective Disorders

Volumn 136, Issue 3, 2012, Pages 751-757

  Battes, Linda C ^a   Pedersen, Susanne S ^a,b   Oemrawsingh, Rohit M ^a   Van Geuns, Robert J ^a   Al Amri, Ibtihal ^a   Regar, Evelyn ^a   De Jaegere, Peter P T ^a   Serruys, Patrick ^a   Van Domburg, Ron T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Beta blocker; Depressive symptoms; Dose

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARVEDILOL; CELIPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; METOPROLOL; NEBIVOLOL; NITRATE; PACLITAXEL; PINDOLOL; PROPRANOLOL; RAPAMYCIN; SOTALOL;

ADULT; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ELUTING STENT; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK REDUCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84857361166     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.09.047     Document Type: Article

References (34)

1. J. Avorn Increased antidepressant use in patients prescribed beta-blockers Journal of the American Medical Association 255 1986 357 360
2. S. Bangalore Cardiovascular protection using beta-blockers: a critical review of the evidence Journal of the American College of Cardiology 50 2007 563 572
3. I. Bjelland The validity of the Hospital Anxiety and Depression Scale. An updated literature review Journal of Psychosomatic Research 52 2002 69 77
4. R.A. Bright, and D.E. Everitt Beta-blockers and depression. Evidence against an association Journal of the American Medical Association 267 1992 1783 1787
5. D.E. Drayer Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers Pharmacotherapy 7 1987 87 91
6. F.A. Elliott Propranolol for the control of belligerent behavior following acute brain damage Annals of Neurology 1 1977 489 491
7. F.M. Gengo Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect Archives of Internal Medicine 147 1987 39 43
8. B.B. Gerstman The incidence of depression in new users of beta-blockers and selected antihypertensives Journal of Clinical Epidemiology 49 1996 809 815
9. A.J. Goble Beta-blocker treatment and depression Archives of Internal Medicine 152 1992 649
10. A.J. Grippo, and A.K. Johnson Biological mechanisms in the relationship between depression and heart disease Neuroscience and Biobehavioral Reviews 26 2002 941 962
11. Herrmann-Lingen Depressed mood, physician-rated prognosis, and comorbidity as independent predictors of 1-year mortality in consecutive medical inpatients Journal of Psychosomatic Research 50 2001 295 301
12. J. Jankovic, and S. Fahn Physiologic and pathologic tremors. Diagnosis, mechanism, and management Annals of Internal Medicine 93 1980 460 465
13. U. Javed, and P.C. Deedwania Beta-adrenergic blockers for chronic heart failure Cardiology in Review 17 2009 287 292
14. M. Kindt Beyond extinction: erasing human fear responses and preventing the return of fear Nature Neuroscience 12 2009 256 258
15. D.T. Ko Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction Journal of the American Medical Association 288 2002 351 357
16. D.S. Krantz Propranolol medication among coronary patients: relationship to type A behavior and cardiovascular response Journal of Human Stress 8 1982 4 12
17. G.N. McNeil Substitution of atenolol for propranolol in a case of propranolol-related depression The American Journal of Psychiatry 139 1982 1187 1188
18. A. Nicholson Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies European Heart Journal 27 2006 2763 2774
19. M.J. Niemela Effect of beta-blockade on heart rate variability in patients with coronary artery disease Journal of the American College of Cardiology 23 1994 1370 1377
20. S.B. Patten, and C. Barbui Drug-induced depression: a systematic review to inform clinical practice Psychotherapy and Psychosomatics 73 2004 207 215
21. S.B. Patten, and E.J. Love Can drugs cause depression? A review of the evidence Journal of Psychiatry & Neuroscience 18 1993 92 102
22. S.S. Pedersen Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting Journal of General Internal Medicine 24 2009 1037 1042
23. P. Plenge, and E.T. Mellerup Pindolol and the acceleration of the antidepressant response Journal of Affective Disorders 75 2003 285 289
24. L.D. Ried Beta-blockers and depression: the more the murkier? The Annals of Pharmacotherapy 32 1998 699 708
25. S.J. Schleifer Digitalis and beta-blocking agents: effects on depression following myocardial infarction American Heart Journal 121 1991 1397 1402
26. J.J. Steffensmeier Do randomized controlled trials always trump case reports? A second look at propranolol and depression Pharmacotherapy 26 2006 162 167
27. G.W. Stone A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease The New England Journal of Medicine 350 2004 221 231
28. L. Theodoresen, and O. Brors The importance of lipid solubility and receptor selectivity of beta-adrenoceptor blocking drugs for the occurrence of symptoms and side-effects in out-patients Journal of Internal Medicine 226 1989 17 23
29. B.Q. Thiessen Increased prescribing of antidepressants subsequent to beta-blocker therapy Archives of Internal Medicine 150 1990 2286 2290
30. Y.R. van Gestel Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis American Journal of Respiratory and Critical Care Medicine 178 2008 695 700
31. J.P. van Melle Betablockers and depression after myocardial infarction: a multicenter prospective study Journal of the American College of Cardiology 48 2006 2209 2214
32. D.E. Verbeek, J. van Riezen, R.A. de Boer, J.P. van Melle, and P. de Jonge A review on the putative association between beta-blockers and depression Heart failure clinics 7 1 2011 89 99
33. R. von Kanel, and S. Begre Depression after myocardial infarction: unraveling the mystery of poor cardiovascular prognosis and role of beta-blocker therapy Journal of the American College of Cardiology 48 2006 2215 2217
34. H.J. Waal Propranolol-induced depression British Medical Journal 2 1967 50